BackEPS Bio Technology Overview

EPS Bio Technology Receivables

Latest receivables for 4183.TWO: $110M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$109.14M
↓ 22.84% YoYΔ $-32.31M vs prior year quarter

Peer trimmed avg / median

Loading

EPS Bio Technology Receivables History

Loading

EPS Bio Technology vs. peers: Receivables Comparison

Loading

EPS Bio Technology Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

EPS Bio Technology (4183.TWO) FAQ

As of the most recent data (June 2026), 4183.TWO shows a receivables of $110M. That compares with $140M in the prior-year period — down 22.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 4183.TWO's receivables is now $110M (was $140M) — a 22.8% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether EPS Bio Technology is outperforming or lagging.

Tracking 4183.TWO's receivables over time shows whether EPS Bio Technology is scaling, shrinking, or reshaping that part of the business. The current reading is $110M That compares with $140M in the prior-year period — down 22.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has EPS Bio Technology's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $110M) with ownership activity and broader fundamentals.